Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
25 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institution that offers technologies to improve human health. The institute undertakes the development of therapies for diseases that include alzheimers, parkinsons, diabetes and other cancers. It provides programs in developmental biology, stem cell research, cancer research, immunology, regenerative medicine, genetics and genomics-programs. Whitehead has affiliation with Massachusetts Institute of Technology in its teaching activities to provide intellectual, collegial and scientific benefits of a leading research university.

Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the k

  
Source:
Document ID
GDPH142621D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Whitehead Institute for Biomedical Research, Pharmaceuticals &Healthcare, Deal Details1012
  Partnerships101
    CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research101
    AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute112
    White Head Institute And Biogen Idec Enter Into Reasearch Agreement131
  Licensing Agreements141
    Syros Pharma Enters into Licensing Agreement with Whitehead Institute142
    Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead162
    Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research181
    Verastem Enters into Licensing Agreement with Whitehead Institute for Biomedical Research191
    Verastem Enters into Licensing Agreement with Whitehead Institute for Biomedical Research to Treat Cancer202
Whitehead Institute for Biomedical Research - Key Competitors221
Key Employees231
Locations And Subsidiaries241
  Head Office241
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Whitehead-Institute-for-Biomedical-Research-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24991>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Whitehead-Institute-for-Biomedical-Research-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24991>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research